X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1932) 1932
Book Review (215) 215
Publication (61) 61
Newsletter (6) 6
Conference Proceeding (5) 5
Book Chapter (4) 4
Magazine Article (3) 3
Book / eBook (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1660) 1660
humans (1551) 1551
male (1012) 1012
female (944) 944
levofloxacin (763) 763
ofloxacin (753) 753
middle aged (711) 711
ofloxacin - therapeutic use (705) 705
adult (698) 698
ofloxacin - adverse effects (677) 677
aged (578) 578
ofloxacin - administration & dosage (459) 459
pharmacology & pharmacy (428) 428
ciprofloxacin (414) 414
fluoroquinolones (379) 379
treatment outcome (356) 356
anti-bacterial agents - therapeutic use (322) 322
anti-infective agents - adverse effects (321) 321
anti-infective agents - therapeutic use (307) 307
anti-bacterial agents - adverse effects (283) 283
adolescent (282) 282
infectious diseases (273) 273
drug therapy, combination (259) 259
antibiotics (251) 251
anti-bacterial agents - administration & dosage (250) 250
microbiology (233) 233
animals (225) 225
aged, 80 and over (214) 214
administration, oral (190) 190
ofloxacin - pharmacology (183) 183
abridged index medicus (175) 175
quinolones (173) 173
microbial sensitivity tests (170) 170
prospective studies (162) 162
drug administration schedule (161) 161
anti-infective agents - administration & dosage (152) 152
drug therapy (150) 150
ofloxacin - pharmacokinetics (149) 149
pharmacokinetics (149) 149
medicine, general & internal (142) 142
double-blind method (131) 131
risk factors (120) 120
time factors (118) 118
child (116) 116
bacterial infections - drug therapy (115) 115
dose-response relationship, drug (113) 113
therapy (112) 112
analysis (110) 110
infections (109) 109
ophthalmology (104) 104
infection (103) 103
health aspects (101) 101
safety (96) 96
acute disease (95) 95
immunology (94) 94
moxifloxacin (93) 93
efficacy (90) 90
retrospective studies (90) 90
ciprofloxacin - therapeutic use (89) 89
toxicology (88) 88
anti-infective agents - pharmacokinetics (87) 87
surgery (87) 87
anti-bacterial agents - pharmacology (85) 85
care and treatment (84) 84
dosage and administration (84) 84
medicine & public health (84) 84
urinary tract infections - drug therapy (84) 84
young adult (84) 84
drugs (82) 82
anti-infective agents - pharmacology (79) 79
ciprofloxacin - adverse effects (79) 79
follow-up studies (79) 79
internal medicine (79) 79
tuberculosis (77) 77
fluoroquinolone (76) 76
norfloxacin (76) 76
resistance (76) 76
toxicity (76) 76
drug interactions (75) 75
fluoroquinolones - adverse effects (75) 75
child, preschool (74) 74
research (74) 74
rats (73) 73
management (72) 72
oncology (72) 72
respiratory tract infections - drug therapy (71) 71
children (70) 70
helicobacter infections - drug therapy (70) 70
drug resistance (69) 69
environmental sciences (69) 69
respiratory system (67) 67
antitubercular agents - therapeutic use (66) 66
gastroenterology & hepatology (66) 66
clarithromycin (64) 64
drug resistance, bacterial (64) 64
administration, topical (63) 63
fluoroquinolones - therapeutic use (63) 63
pneumonia (63) 63
community-acquired infections - drug therapy (60) 60
complications and side effects (60) 60
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1731) 1731
French (47) 47
Japanese (37) 37
Spanish (36) 36
Russian (30) 30
German (28) 28
Chinese (9) 9
Italian (7) 7
Portuguese (4) 4
Turkish (4) 4
Danish (2) 2
Hungarian (2) 2
Polish (2) 2
Swedish (2) 2
Dutch (1) 1
Finnish (1) 1
Hebrew (1) 1
Norwegian (1) 1
Romanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American Academy of Dermatology, ISSN 0190-9622, 2015, Volume 72, Issue 5, pp. AB124 - AB124
Journal Article
JORNAL BRASILEIRO DE PNEUMOLOGIA, ISSN 1806-3713, 09/2010, Volume 36, Issue 5, pp. 641 - 656
The main objectives of tuberculosis therapy are to cure the patients and to minimize the possibility of transmission of the bacillus to healthy subjects.... 
MYCOBACTERIUM-TUBERCULOSIS | Drug interactions | Drug toxicity, Tuberculosis, multidrug-resistant | OFLOXACIN | Pharmacologic actions | PREGNANCY | Tuberculosis | PHARMACOKINETICS | RESPIRATORY SYSTEM | MULTIDRUG-RESISTANT TUBERCULOSIS | FLUOROQUINOLONES | AGENTS | Antibiotics, antitubercular | NEPHROTOXICITY | ETHIONAMIDE
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2009, Volume 361, Issue 26, pp. 2507 - 2517
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2012, Volume 367, Issue 16, pp. 1508 - 1518
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
American Journal of Dermatopathology, ISSN 0193-1091, 05/2013, Volume 35, Issue 3, pp. 343 - 350
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 03/2008, Volume 52, Issue 3, pp. 852 - 857
Journal Article
The American Journal of Gastroenterology, ISSN 0002-9270, 02/2006, Volume 101, Issue 2, pp. 243 - 247
Journal Article
Infection Control and Hospital Epidemiology, ISSN 0899-823X, 03/2005, Volume 26, Issue 3, pp. 273 - 280
Journal Article